Non-invasive prenatal diagnosis of beta-thalassemia and sickle-cell disease using pyrophosphorolysis-activated polymerization and melting curve analysis

Prenatal Diagnosis

Volumn 32, Issue 6, 2012, Pages 578-587

  Phylipsen, Marion ^a   Yamsri, Supawadee ^b   Treffers, Emmely E ^a   Jansen, Diahann T S L ^a   Kanhai, Warsha A ^a   Boon, Elles M J ^a   Giordano, Piero C ^a   Fucharoen, Supan ^b   Bakker, Egbert ^a   Harteveld, Cornelis L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ALLELE; ARTICLE; CHORION VILLUS SAMPLING; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FETUS; GENETIC LINKAGE; GENETIC RISK; GLOBIN GENE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LABORATORY DEVICE; MALE; MUTATIONAL ANALYSIS; NON INVASIVE MEASUREMENT; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMERIZATION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PYROPHOSPHOROLYSIS ACTIVATED POLYMERIZATION ASSAY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA MAJOR; WILD TYPE;

ALLELES; ANEMIA, SICKLE CELL; BETA-GLOBINS; BETA-THALASSEMIA; DNA; FATHERS; FEMALE; GENETIC LINKAGE; GENOTYPING TECHNIQUES; HETEROZYGOTE DETECTION; HUMANS; LEUKOCYTES; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMERIZATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84861480612     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3864     Document Type: Article

References (32)

1. Weatherall DJ, Williams TN, Allen SJ, O'Donnell A. The population genetics and dynamics of the thalassemias. Hematol Oncol Clin North Am 2010;24(6):1021-31.
2. Henderson S, Timbs A, McCarthy J, Gallienne A, Van MM, Masters G, et al. Incidence of haemoglobinopathies in various populations - the impact of immigration. Clin Biochem 2009;42(18):1745-56.
3. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86(6):480-7.
4. Bouva MJ, Mohrmann K, Brinkman HB, Kemper-Proper EA, Elvers B, Loeber JG, et al. Implementing neonatal screening for haemoglobinopathies in the Netherlands. J Med Screen 2010;17(2):58-65.
5. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27(1):1-7.
6. Nicolaides K, Brizot ML, Patel F, Snijders R. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13weeks' gestation. Lancet 1994;344(8920):435-9.
7. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350(9076):485-7.
8. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339(24):1734-8.
9. van der Schoot CE, Hahn S, Chitty LS. Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008;13(2):63-8.
10. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
11. Scheffer PG, van der Schoot CE, Page-Christiaens GC, Bossers B, van EF, de HM. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010;115(1):117-26.
12. Devaney SA, Palomaki GE, Scott JA, Bianchi DW. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA 2011;306(6):627-36.
13. Lun FM, Chiu RW, Allen Chan KC, Yeung LT, Kin LT, Dennis Lo YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008;54(10):1664-72.
14. Boon EM, Schlecht HB, Martin P, Daniels G, Vossen RH, den Dunnen JT, et al. Y chromosome detection by Real Time PCR and pyrophosphorolysis-activated polymerisation using free fetal DNA isolated from maternal plasma. Prenat Diagn 2007;27(10):932-7.
15. Liu Q, Sommer SS. Pyrophosphorolysis-activated polymerization (PAP): application to allele-specific amplification. Biotechniques 2000;29(5):1072-6, 1078, 1080.
16. Liu Q, Sommer SS. PAP: detection of ultra rare mutations depends on P* oligonucleotides: "sleeping beauties" awakened by the kiss of pyrophosphorolysis. Hum Mutat 2004;23(5):426-36.
17. Liu Q, Sommer SS. Pyrophosphorolysis-activatable oligonucleotides may facilitate detection of rare alleles, mutation scanning and analysis of chromatin structures. Nucleic Acids Res 2002;30(2):598-604.
18. Giordano PC, Harteveld CL, Heister AJ, Batelaan D, van DP, Plug R, et al. The molecular spectrum of beta-thalassemia and abnormal hemoglobins in the allochthonous and autochthonous Dutch population. Community Genet 1998;1(4):243-51.
19. Giardine B, van BS, Kaimakis P, Riemer C, Miller W, Samara M, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat 2007;28(2):206.
20. Antonarakis SE, Boehm CD, Giardina PJ, Kazazian HH, Jr. Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster. Proc Natl Acad Sci USA 1982;79(1):137-41.
21. Orkin SH, Kazazian HH, Jr., Antonarakis SE, Goff SC, Boehm CD, Sexton JP, et al. Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 1982;296(5858):627-31.
22. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86.
23. Galbiati S, Smid M, Gambini D, Ferrari A, Restagno G, Viora E, et al. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005;117(2-3):243-8.
24. Kaufmann JO, Demirel-Gungor G, Selles A, Hudig C, Steen G, Ponjee G, et al. Feasibility of nonselective testing for hemoglobinopathies in early pregnancy in The Netherlands. Prenat Diagn 2011;31(13):1259-63.
25. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH, et al. Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet 1984;36(6):1239-58.
26. Fearnhead P, Harding RM, Schneider JA, Myers S, Donnelly P. Application of coalescent methods to reveal fine-scale rate variation and recombination hotspots. Genetics 2004;167(4):2067-81.
27. Old JM, Heath C, Fitches A, Thein SL, Jeffreys AJ, Petrou M, et al. Meiotic recombination between two polymorphic restriction sites within the beta globin gene cluster. J Med Genet 1986;23(1):14-8.
28. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002;360(9338):998-1000.
29. Fucharoen G, Tungwiwat W, Ratanasiri T, Sanchaisuriya K, Fucharoen S. Prenatal detection of fetal hemoglobin E gene from maternal plasma. Prenat Diagn 2003;23(5):393-6.
30. Chan K, Yam I, Leung KY, Tang M, Chan TK, Chan V. Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis of beta-thalassemia: a feasibility study in southern Chinese. Eur J Obstet Gynecol Reprod Biol 2010;150(1):28-33.
31. Ding C. MALDI-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma. Methods Mol Biol 2008;444:253-67.
32. Ding C, Cantor CR. Direct molecular haplotyping of long-range genomic DNA with M1-PCR. Proc Natl Acad Sci USA 2003;100(13):7449-53.